Multiplex Assays Market Business Opportunities, Challenges, Drivers and Restraint Research Report by 2030
The global multiplex assays market size is expected to reach USD 5.57 billion by 2030, according to a new study by Polaris Market Research.
The key factors driving the market’s growth include adopting multiplex assays across various verticals such as health services and others. Due to the growing use of customized treatment and benefits over standard tests, the market is expected to rise rapidly. Medical science, which has gained popularity in recent years, strives to provide individual patients with tailored therapies based on the molecular foundation of their disease.
Based on the type, the nucleic acid segment accounted for the leading share in the industry in 2021. This is due to the rising use of nucleic acids, ease of configuration to detect practically any target, low sample volume requirements, and level of automation to be achieved. A rise in the use of molecular diagnostic tests developed to diagnose diseases, such as human genetic markers, such as cancer, and genetic markers for disease predisposition also contributes to the economic development of the nucleic acid-based segment.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/multiplex-assays-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)
Market players such as Luminex Corporation, Enzo Life Sciences, Inc., Promega Corporation, Meso Scale Diagnostics, Quanterix, Thermo Fisher Scientific Inc., Qiagen N.V., Illumina, Inc, Shimadzu Biotech, Abcam plc, Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Randox Laboratories, Merck KGaA, Agilent Technologies, Inc., Olink, DiaSorin S.p.A., Antigenix America, Inc., Siemens Healthineers, PerkinElmer, Inc., Boster Biological Technology, Seegene, and Cayman Chemical Company are some key players operating in the global market.
In August 2021, The BD COR System, a new automated diagnostic system from Becton, Dickinson, and Company, was released. In centralized laboratories across the U.S., the system uses robots and sample management software algorithms for genetic disease testing. Thus, the development of new technologies by major players and adoption of them across various laboratories is boosting the market growth during the forecast period.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/multiplex-assays-market/inquire-before-buying
(You may enquire a report quote OR available discount offers to our sales team before purchase.)
Polaris Market Research has segmented the multiplex assays market report based on type, technology, application, end-user, and region:
Multiplex assays, Type Outlook (Revenue – USD Billion, 2018 – 2030)
- Planar Protein
- Bead-Based Protein
- Other Protein
- Nucleic Acid
- Planar Nucleic Acid
- Bead-Based Nucleic Acid
- Other Nucleic Acid
Multiplex assays, Technology Outlook (Revenue – USD Billion, 2018 – 2030)
- Flow Cytometry
- Fluorescence Detection
- Multiplex Real-Time PCR
- Other Technologies
Multiplex assays, Application Outlook (Revenue – USD Billion, 2018 – 2030)
- Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
- Clinical Diagnostics
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
Multiplex assays, End-User Outlook (Revenue – USD Billion, 2018 – 2030)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Research Institutes
- Reference Laboratories
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Polaris Market Research